Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
biochemistry, genetics and molecular biology
Expression profiling and significance of VEGF-A, VEGFR2, VEGFR3 and related proteins in endometrial carcinoma
Cytokine, Volume 68, No. 2, Year 2014
Notification
URL copied to clipboard!
Description
Background: Angiogenesis plays a key role in the progression of various tumors, including endometrial carcinomas. Several cytokines and their associated receptors are shown to be involved, particularly VEGF-A with VEGFR1, -2 and -3. Methods: The expressions of VEGF-A, VEGFR2 and VEGFR3 were studied in by immunohistochemistry in 76 endometrial carcinoma specimens. VEGFR2 and VEGFR3 receptor expression were also studied by qRT-PCR in 17 tumors in comparison to normal endometrium. The expression profiles were correlated with tumor type, grade, stage, lymphovascular invasion, disease free survival, and the expressions of other cytokine receptors (EGFR, CXCR1 and CXCR2). Results: Immunohistochemically, 63% of endometrial cancers expressed VEGF-A, 55% VEGFR2 and 26% VEGFR3. VEGFR3 was significantly correlated with tumor stage (p= 0.02), with a trend towards poorer disease free survival (p= 0.09). VEGF-A was significantly correlated with microvessel density (p< 0.01). Using qRT-PCR, increased expression of VEGFR2 (17.2-fold) and VEGFR3 (21.9-fold) was seen in endometrial carcinomas compared with normal endometrium, with significant correlations among the expression levels of VEGFR2, VEGFR3, EGFR, CXCR1 and CXCR2. Conclusion: Our study suggests that evaluation of VEGFR3 expression in tumors may provide prognostic data, and help identify patients who would best benefit from anti-angiogenic therapeutic agents. This is the first report showing correlations between the expressions levels of the different receptors. © 2014 Elsevier Ltd.
Authors & Co-Authors
Wang, Jayson
United Kingdom, London
Imperial College London
Taylor, Alexandra
United Kingdom, Sutton
Royal Marsden Hospital
Showeil, Rania
United Kingdom, London
Imperial College London
Trivedi, Pritesh
United Kingdom, London
Imperial College London
Horimoto, Yoshiya
United Kingdom, London
Imperial College London
Bagwan, Izhar
United Kingdom, Guildford
Royal Surrey County Hospital
Ewington, Lauren
United Kingdom, London
Imperial College London
Lam, Eric W.F.
United Kingdom, London
Imperial College London
El-Bahrawy, Mona A.
United Kingdom, London
Imperial College London
Egypt, Alexandria
Faculty of Medicine
Statistics
Citations: 54
Authors: 9
Affiliations: 4
Identifiers
Doi:
10.1016/j.cyto.2014.04.005
ISSN:
10434666
e-ISSN:
10960023
Research Areas
Cancer